Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hopemark Health is a comprehensive healthcare provider specializing in neurology, neuropsychology, and behavioral health services. Formerly known as CNNH NeuroHealth, the organization provides integrated care for children, adolescents, and adults with neurodevelopmental and mental health disorders. Their multidisciplinary approach includes diagnostic evaluations, medication management, and various therapeutic interventions such as Applied Behavior Analysis (ABA) and speech therapy. The company also engages in clinical research and trials to advance treatments for neurological conditions. By combining medical expertise with behavioral support, Hopemark Health aims to improve outcomes for patients with complex brain-based disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hopemark Health.